Principle Research Solutions
Principle Research Solutions
  • Home
  • Current Studies
  • Mission
  • Services
  • More
    • Home
    • Current Studies
    • Mission
    • Services

  • Home
  • Current Studies
  • Mission
  • Services

Notalgia Paresthetica (itchy back)

The objective of this study is to assess the efficacy and safety of twice daily oral difelikefalin for the treatment of adult participants with Pruritus (itch) associated with Notalgia Paresthetica (N.P.). 

Sign Up/ Request info

CARA Therapeutics ITCHY BACK STUDY

Participation Information

Volunteers needed for a 15  week long clinical trial with up to 7 office visits for an investigational product. Up to $2,410.00 stipend available.


To Qualify, you must meet the following INCLUSION CRITERIA:

1.)   18 to 80 Years of Age

2.)   Current Notalgia Paresthetica 

3.)   Moderate to Severe condition (to be assessed at your in office screening visit)


To Qualify, you must NOT meet the following EXCLUSION CRITERIA:

1.)   Itch (pruritus) caused by something other than N.P. 

2.)  Unwilling to discontinue current Notalgia Paresthetica treatments

3.)  Female who is pregnant or breastfeeding



ClinicalTrials.gov Identifier:  NCT  05978063

https://clinicaltrials.gov/study/NCT05978063?term=cara&intr=notalgia%20paresthetica&rank=2


Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Better yet, see us in person!

We love our patients, so feel free to visit during normal business hours.

Principle Research Solutions,llc

510 S Cowley St. Spokane, WA 99202

(509) 474-1107 ext 8 Dermatology Research

Hours

Mon

09:00 am – 05:00 pm

Tue

09:00 am – 05:00 pm

Wed

09:00 am – 05:00 pm

Thu

09:00 am – 05:00 pm

Fri

09:00 am – 05:00 pm

Sat

Closed

Sun

Closed

Photo Gallery

Copyright © 2025 Principle Research Solutions,llc - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept